Product NDC: | 17478-030 |
Proprietary Name: | Sublimaze |
Non Proprietary Name: | FENTANYL CITRATE |
Active Ingredient(s): | 50 ug/mL & nbsp; FENTANYL CITRATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-030 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016619 |
Marketing Category: | NDA |
Start Marketing Date: | 20120322 |
Package NDC: | 17478-030-55 |
Package Description: | 25 AMPULE in 1 CARTON (17478-030-55) > 5 mL in 1 AMPULE |
NDC Code | 17478-030-55 |
Proprietary Name | Sublimaze |
Package Description | 25 AMPULE in 1 CARTON (17478-030-55) > 5 mL in 1 AMPULE |
Product NDC | 17478-030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FENTANYL CITRATE |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120322 |
Marketing Category Name | NDA |
Labeler Name | Akorn, Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |